Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69 | 73 | 97 | 112 | 122 |
| Receivables | 3 | 2 | N/A | N/A | 0 |
| TOTAL | $73 | $92 | $97 | $112 | $123 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 25 | 25 |
| Other Non-Current Assets | 5 | 0 | 0 | 0 | 0 |
| TOTAL | $5 | $N/A | $N/A | $25 | $25 |
| Total Assets | $77 | $92 | $97 | $137 | $148 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5 | 14 | 10 | 5 | 3 |
| TOTAL | $5 | $14 | $10 | $5 | $3 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5 | $14 | $10 | $5 | $3 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,917 | 1,917 | 1,917 | 1,917 | 1,917 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -121 | -115 | -105 | -59 | -46 |
| TOTAL | $72 | $78 | $87 | $132 | $144 |
| Total Liabilities And Equity | $77 | $92 | $97 | $137 | $148 |